Elagolix Sodium API Suppliers & Bulk Manufacturers
Available Forms: API (drug substance)
Available Strengths: USP grade or in-house specification
Reference Brands: Orilissa, Oriahnn
Category: Active Pharmaceutical Ingredient
Elagolix sodium is an oral GnRH receptor antagonist used in women's health products. It is sourced by hormone formulators, CDMOs and R&D teams with contained facilities.
Manufacture or export Elagolix Sodium API? List it or send an offer →
Product Description:
Elagolix is an oral, non-peptide gonadotropin-releasing hormone (GnRH) receptor antagonist that reduces the release of pituitary hormones and so lowers oestrogen levels. It is approved in the US for moderate to severe pain associated with endometriosis (reference brand: Orilissa) and, combined with estradiol and norethindrone acetate, for heavy menstrual bleeding associated with uterine fibroids in premenopausal women (reference brand: Oriahnn).
Specification at a glance
| Traded form | Monosodium salt; single enantiomer; freely water-soluble powder whose solid form and hygroscopicity should be confirmed with the supplier |
|---|---|
| CAS number | 832720-36-2 |
| Molecular formula | C32H29F5N3NaO5 |
| Molecular weight | 653.6 g/mol |
| Pharmacopoeia | No pharmacopoeia monograph found. Elagolix sodium was listed by USP for monograph development and its current USP status is unverified; otherwise supplied to an in-house specification. |
Regulatory files and timing
The FDA list of Drug Master Files (third quarter 2026) shows 21 active Type II API DMFs for this molecule. There is a fair choice of sources, so compare documents and impurity profiles, not just price. For Europe, ask whether the supplier holds a CEP or an EU ASMF and, for imports into the EU, a written confirmation.
Generic or biosimilar entry. United States: Patent expiry; entry not confirmed (Jul 2029). European Union: No confirmed date.
Handling and quality points
Elagolix acts on the reproductive hormone axis, so it is usually handled as a potent compound with reproductive-toxicity controls, closed transfers and verified cleaning, especially on shared lines. The sodium salt can take up moisture, so water content, packing and storage conditions need attention. The specification should include chiral purity and control of the synthesis impurities identified in the supplier's ICH M7 assessment.
Send an API enquiry All specialty APIs
Brand names are trademarks of their respective owners and identify the reference medicine only. Information is general and was checked in October 2026; confirm specifications and filings with the supplier before purchase.
Elagolix Sodium API — third party manufacturing & bulk supply
Elagolix Sodium API is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Elagolix Sodium API is supplied as API (drug substance) — a dosage form priced by order value, so the indicative MOQ is a minimum order value of USD 5,000 per product. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Elagolix Sodium API listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Elagolix Sodium API →Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.
Frequently Asked Questions
Buyers usually ask for the GMP certificate, a US DMF letter of access, a CoA with chiral purity, water and related substances, and stability data. Occupational exposure and containment information is important because of the hormonal activity. A nitrosamine risk assessment is now part of the standard pack.
Because it suppresses reproductive hormones, most makers place elagolix in a potent-compound band and handle it with closed systems or isolators. Ask the supplier for the occupational exposure limit they use, how it was derived and their cleaning validation limits. These figures will drive your own facility risk assessment.
Yes. We link licensed manufacturers, CDMOs and research teams with GMP-compliant elagolix sodium producers that have suitable containment. PharmaTradz reviews their documents first, and your details are not passed on until both sides agree.
Related Products
Bictegravir Sodium API
Strength:
USP grade or in-house specification
Form: API (drug substance)
Reference Brands: Biktarvy
View DetailsRilpivirine Hydrochloride API
Strength:
USP grade or in-house specification
Form: API (drug substance)
Reference Brands: Edurant, Complera, Odefsey, Juluca
View DetailsCariprazine Hydrochloride API
Strength:
Supplied to an in-house or pharmacopoeial specification
Form: API (drug substance)
Reference Brands: Vraylar, Reagila
View DetailsBrentuximab Vedotin Drug Substance
Strength:
Supplied to an in-house or pharmacopoeial specification
Form: Drug substance (bulk)
Reference Brands: Adcetris
View DetailsCabazitaxel API
Strength:
Supplied to an in-house or pharmacopoeial specification
Form: API (drug substance)
Reference Brands: Jevtana
View DetailsBlinatumomab Drug Substance
Strength:
Supplied to an in-house or pharmacopoeial specification
Form: Drug substance (bulk)
Reference Brands: Blincyto
View DetailsRifaximin API
Strength:
USP grade or in-house specification
Form: API (drug substance)
Reference Brands: Xifaxan, Normix
View DetailsBosutinib Monohydrate API
Strength:
USP grade or in-house specification
Form: API (drug substance)
Reference Brands: Bosulif
View DetailsUsually answered within 48 hours | GMP documents shared before you commit